Video Interview: Professor Ira Shoulson
Prana Biotechnology (ASX:PBT, NASDAQ: PRAN) is pleased to invite investors to watch a video interview of Professor Ira Shoulson, following his appointment to the Board of Directors of Prana Biotechnology
In the interview, Professor Shoulson comments on:
- Rationale for joining the Board of Directors and his background;
- Significance of the recent REACH2HD trial of PBT2 in Huntington disease (HD) patients;
- The state of therapeutics for patients with HD;
- Recent IMAGINE trial of PBT2 in Alzheimer’s disease (HD) patients; and
- An overview of Prana’s library of compounds.
The video interview is available via the following link: Interview with Professor Ira Shoulson
You can access access other PBT webcasts at BRR media.